SCHEMBL8470652

SCHEMBL8470652

COc1ccc(NC(=O)N2CC(OC)C[C@@H]2C(=O)Nc2ccc3c(c2)CCN(C)CC3)cc1

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HCRTR1 O43613 1/20 0.50
HCRTR2 O43614 1/20 0.50
TSHR P16473 1/20 0.50
CYP2C9 P11712 1/20 0.49
CYP2C19 P33261 1/20 0.49
NPC1 O15118 3/20 0.48
RAB9A P51151 3/20 0.48
POLB P06746 1/20 0.48
KCNA1 Q09470 1/20 0.45
KCNAB1 Q14722 1/20 0.45
F10 P00742 3/20 0.44
ALDH1A1 P00352 1/20 0.44
MAPT P10636 3/20 0.43
PKM P14618 1/20 0.43
NFKB1 P19838 1/20 0.43
MAOB P27338 1/20 0.43
NFKB2 Q00653 1/20 0.43
RELA Q04206 1/20 0.43
SMN1; SMN2 Q16637 1/20 0.43
TP53 P04637 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12371419 1.00 HCRTR1 (0.50) HCRTR1HCRTR2TSHRCYP2C9CYP2C19
SCHEMBL8471226 0.90 F10 (0.54) HCRTR1HCRTR2TSHRCYP2C9CYP2C19
SCHEMBL15436018 0.90 F10 (0.48) HCRTR1HCRTR2TSHRNPC1RAB9A
SCHEMBL12371451 0.90 F10 (0.48) HCRTR1HCRTR2TSHRNPC1RAB9A
SCHEMBL14434220 0.90 NPC1 (0.47) HCRTR1HCRTR2TSHRCYP2C9CYP2C19
SCHEMBL12101351 0.89 F10 (0.47) CYP2C9CYP2C19NPC1RAB9APOLB
SCHEMBL15436217 0.89 NPC1 (0.47) HCRTR1HCRTR2TSHRNPC1RAB9A
SCHEMBL13104199 0.89 F10 (0.47) CYP2C9CYP2C19NPC1RAB9APOLB
SCHEMBL12371447 0.89 F10 (0.45) HCRTR1HCRTR2TSHRCYP2C9CYP2C19
SCHEMBL12371438 0.89 NPC1 (0.47) HCRTR1HCRTR2TSHRNPC1RAB9A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1818330-A1 Substituted proline amides, preparation and use as medicaments thereof Boehringer Ingelheim Pharma GmbH & Co.KG (DE) 2007-08-15 EP disclosed